CELCUITY INC. - COMMON STOCK

Celcuity To Present at Upcoming TD Cowen and Jefferies Investor Conferences

21 5月 2025 04:05:00 条件 Nasdaq GlobeNewswire

Celcuity Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update

14 5月 2025 13:01:00 条件 Nasdaq GlobeNewswire

Celcuity Inc. Schedules Release of First Quarter 2025 Financial Results and Webcast/Conference Call

07 5月 2025 04:05:00 条件 Nasdaq GlobeNewswire

Celcuity To Present at Upcoming Needham and Stifel Investor Conferences

01 4月 2025 04:05:00 条件 Nasdaq GlobeNewswire

Celcuity Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

31 3月 2025 13:01:00 条件 Nasdaq GlobeNewswire

Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2024 Financial Results and Webcast/Conference Call 

24 3月 2025 04:05:00 条件 Nasdaq GlobeNewswire

Celcuity to Participate at Upcoming Cowen and Leerink Investor Conferences

25 2月 2025 04:05:00 条件 Nasdaq GlobeNewswire

Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer Symposium

11 12月 2024 04:05:00 条件 Nasdaq GlobeNewswire

Celcuity Inc. Reports Third Quarter Financial Results and Provides Corporate Update

14 11月 2024 13:01:00 条件 Nasdaq GlobeNewswire

Celcuity Inc. To Present at Upcoming Stifel and Jefferies Investor Conferences

12 11月 2024 04:05:00 条件 Nasdaq GlobeNewswire

Celcuity Inc. Schedules Release of Third Quarter 2024 Financial Results and Webcast/Conference Call

07 11月 2024 04:05:00 条件 Nasdaq GlobeNewswire

Celcuity Inc. Reports Second Quarter Financial Results and Provides Corporate Update

14 8月 2024 13:01:00 条件 Nasdaq GlobeNewswire

Celcuity Inc. Schedules Release of Second Quarter 2024 Financial Results and Webcast/Conference Call

07 8月 2024 04:05:00 条件 Nasdaq GlobeNewswire

Celcuity To Participate in Jefferies Global Healthcare Conference

03 6月 2024 13:01:00 条件 Nasdaq GlobeNewswire

Celcuity Announces Pricing of Underwritten Common Stock Offering

30 5月 2024 04:36:22 条件 Nasdaq GlobeNewswire

Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Treatment for HR+/HER2- Advanced Breast Cancer and Secures Approximately $62 Million Debt Financing

30 5月 2024 04:00:01 条件 Nasdaq GlobeNewswire

Celcuity Inc. Reports First Quarter Financial Results and Provides Corporate Update

15 5月 2024 13:01:00 条件 Nasdaq GlobeNewswire

Celcuity Inc. Schedules Release of First Quarter 2024 Financial Results and Webcast/Conference Call

08 5月 2024 04:05:00 条件 Nasdaq GlobeNewswire

Celcuity To Present at Upcoming Needham and Stifel Investor Conferences

04 4月 2024 04:05:00 条件 Nasdaq GlobeNewswire

Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

27 3月 2024 13:01:00 条件 Nasdaq GlobeNewswire